@FiercePharma: No obvious China baby bump for J&J as one-child policy ends. FiercePharmaAsia article | Follow @FiercePharma
@EricPFierce: Novartis is revamping its manufacturing after having disposed of 25 plants. FiercePharmaManufacturing article | Follow @EricPFierce
@CarlyHFierce: ICYMI: U.K. cost watchdog nixes pricey biologics for moderate rheumatoid arthritis. Article | Follow @CarlyHFierce
> AstraZeneca's ($AZN) new ovarian cancer drug Lynparza got a "breakthrough" designation from the FDA for a new use in prostate cancer. Report
> Top cancer centers in the U.S. urged broader use of human papillomavirus vaccines such as GlaxoSmithKline's ($GSK) Cervarix and Merck & Co.'s ($MRK) Gardasil to prevent cancer linked to the virus. Report
> Biosimilars got a boost in Britain this week as England's cost-effectiveness watchdog said patients needing expensive biologic meds should start with "the least expensive drug." Report
> GlaxoSmithKline's consumer business in Nigeria got a buyout offer for its drinks bottling and distribution business there. Report
> Abbott Laboratories ($ABT) posted lower-than-expected quarterly sales and forecast 2016 earnings below expectations. Report
Medical Device News
@FierceMedDev: Israeli VC backed by Philips and Teva looking to invest $26M in promising med tech startups. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Sony, Carlyle Group, KKR among bidders for Toshiba's imaging unit, expected to fetch $3B+. Article | Follow @VarunSaxena2
@EmilyWFierce: Dog flu sweeps the U.S. with two more confirmed cases in Washington state. FierceAnimalHealth story | Follow @EmilyWFierce
> Investor urges J&J to spin out poor-performing device, consumer businesses. Report
> HeartWare succumbs to activist investors, calls off planned Valtech purchase. Story
> CMS draws blood, says Theranos poses 'immediate jeopardy to patient health.' Article
Biotech News
@FierceBiotech: UT Southwestern team IDs next-gen approach to fighting pancreatic cancer. FierceBiotechResearch article | Follow @FierceBiotech
@JohnCFierce: Turn out the lights, the party is over: Gov't finds Theranos lab poses 'immediate jeopardy to patient safety.' CNBC article | Follow @JohnCFierce
> Neos wins FDA approval for a melts-in-your-mouth take on Adderall for ADHD. Article
> The top 10 (possible) blockbusters that (might) launch this year. More
> Venetoclax grabs third FDA 'breakthrough' for blood cancer. Report
CRO News
> PRA recruits a U.K. marketing firm to help it reach more patients. Report
> In the midst of cuts, Parexel signs new research deal. More
> Parexel dims its revenue expectations despite a solid quarter. Story
> Icon launches new tech with promise to simplify adaptive trials. News
> BioClinica notches up another deal, this time with EPS. Article
Pharma Manufacturing News
> Lilly closing two animal health manufacturing plants picked up from Novatis. Article
> Baxter recalls saline, other products, contaminated by cardboard, cloth and skin. News
> Novartis revamping manufacturing after hiving off 25 plants. More
> GSK production coming up short for meningitis B vax, causing some shortages. Item
> Recipharm wrapping up its $105M deal for Indian sterile injectables maker Nitin. Article
Pharma Asia News
> India's Supreme Court allows Cipla move in Roche patent case. News
> Sino Biopharma's asset management deal drawing negative reviews. Report
> 3SBio buys a larger stake in CP Guojian Pharma for $150M. Story
> Novartis expects India's Sun to meet February U.S. generic Gleevec launch. More
> Another legal test for U.S. in case of Chinese scientists accused of stealing GSK secrets. Article
And Finally... One percent of U.S. doctors are responsible for a third of malpractice payments. Report